GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » Shiller PE Ratio

Zenotech Laboratories (BOM:532039) Shiller PE Ratio : (As of May. 08, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zenotech Laboratories Shiller PE Ratio Historical Data

The historical data trend for Zenotech Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenotech Laboratories Shiller PE Ratio Chart

Zenotech Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zenotech Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Zenotech Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenotech Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's Shiller PE Ratio falls into.


;
;

Zenotech Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zenotech Laboratories's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Zenotech Laboratories's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.21/157.3313*157.3313
=0.210

Current CPI (Mar. 2025) = 157.3313.

Zenotech Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 -1.414 99.841 -2.228
201509 -1.348 101.753 -2.084
201512 -1.310 102.901 -2.003
201603 -1.205 102.518 -1.849
201606 -1.610 105.961 -2.391
201609 -1.460 105.961 -2.168
201612 -1.530 105.196 -2.288
201703 -1.180 105.196 -1.765
201706 -1.520 107.109 -2.233
201709 -0.580 109.021 -0.837
201712 -0.150 109.404 -0.216
201803 -0.270 109.786 -0.387
201806 -0.403 111.317 -0.570
201809 -0.440 115.142 -0.601
201812 -0.150 115.142 -0.205
201903 0.420 118.202 0.559
201906 0.300 120.880 0.390
201909 0.340 123.175 0.434
201912 1.120 126.235 1.396
202003 0.000 124.705 0.000
202006 -0.060 127.000 -0.074
202009 -0.340 130.118 -0.411
202012 0.010 130.889 0.012
202103 0.190 131.771 0.227
202106 0.570 134.084 0.669
202109 0.160 135.847 0.185
202112 0.590 138.161 0.672
202203 2.310 138.822 2.618
202206 0.620 142.347 0.685
202209 0.450 144.661 0.489
202212 0.230 145.763 0.248
202303 0.600 146.865 0.643
202306 0.240 150.280 0.251
202309 0.460 151.492 0.478
202312 0.550 152.924 0.566
202403 0.110 153.035 0.113
202406 0.210 155.789 0.212
202409 0.220 157.882 0.219
202412 0.280 158.323 0.278
202503 0.210 157.331 0.210

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zenotech Laboratories  (BOM:532039) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zenotech Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenotech Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories Headlines

No Headlines